MCM
TMO icon

Marathon Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Marathon Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$517K Sell
1,052
-75
-7% -$40.7K 0.12% 101
2025
Q4 		$653K Hold
1,127
– – 0.14% 93
2025
Q3 		$547K Hold
1,127
– – 0.13% 95
2025
Q2 		$457K Hold
1,127
– – 0.12% 97
2025
Q1 		$561K Sell
1,127
-50
-4% -$27.1K 0.15% 85
2024
Q4 		$612K Buy
1,177
+2
+0.2% +$1.1K 0.15% 84
2024
Q3 		$727K Hold
1,175
– – 0.18% 79
2024
Q2 		$650K Hold
1,175
– – 0.17% 78
2024
Q1 		$683K Sell
1,175
-25
-2% -$14K 0.16% 80
2023
Q4 		$637K Hold
1,200
– – 0.16% 87
2023
Q3 		$607K Hold
1,200
– – 0.15% 85
2023
Q2 		$626K Hold
1,200
– – 0.15% 85
2023
Q1 		$692K Hold
1,200
– – 0.17% 84
2022
Q4 		$661K Hold
1,200
– – 0.18% 77
2022
Q3 		$609K Hold
1,200
– – 0.17% 84
2022
Q2 		$652K Buy
+1,200
New +$661K 0.21% 75
2022
Q1 		– Sell
-1,225
Closed -$817K – 162
2021
Q4 		$817K Sell
1,225
-25
-2% -$15.6K 0.19% 76
2021
Q3 		$715K Hold
1,250
– – 0.16% 88
2021
Q2 		$630K Hold
1,250
– – 0.15% 83
2021
Q1 		$570K Hold
1,250
– – 0.15% 81
2020
Q4 		$582K Sell
1,250
-50
-4% -$23.4K 0.17% 73
2020
Q3 		$573K Sell
1,300
-76
-6% -$31.4K 0.21% 69
2020
Q2 		$499K Buy
1,376
+76
+6% +$25.5K 0.19% 66
2020
Q1 		$368K Sell
1,300
-60
-4% -$18.9K 0.17% 69
2019
Q4 		$441K Buy
+1,360
New +$412K 0.15% 80

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Marathon Capital Management's TMO Position: Q1 2026 in Review

Marathon Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 6.7% in Q1 2026, selling an estimated $40.7K and leaving 1,052 shares worth $517K. The position accounts for 0.12% of the portfolio, ranked #101.

Marathon Capital Management first reported a position in TMO in Q4 2019 and has held it in 25 quarters since. The position peaked at $817K in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Marathon Capital Management held 1,052 shares of Thermo Fisher Scientific worth $517K as of Q1 2026.
  • Marathon Capital Management sold 75 Thermo Fisher Scientific shares in Q1 2026, an estimated $40.7K.
  • Thermo Fisher Scientific made up 0.12% of Marathon Capital Management's portfolio in Q1 2026, its #101 holding.
  • Marathon Capital Management first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 25 quarters since.
  • Marathon Capital Management's Thermo Fisher Scientific position peaked at $817K in Q4 2021.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Marathon Capital Management's 13F filing for Q1 2026, filed 14 May 2026.